£325.00

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Europe

Price data last checked 61 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 30 days • 30 data points (No recent data available)

Historical
Generating forecast...
£325.00 £308.75 £315.25 £321.75 £328.25 £334.75 £341.25 26 January 2026 02 February 2026 09 February 2026 16 February 2026 24 February 2026

Price Distribution

Price distribution over 30 days • 1 price levels

Days at Price
30 days 0 8 15 23 30 £325 Days at Price

Price Analysis

Most common price: £325 (30 days, 100.0%)

Price range: £325 - £325

Price levels: 1 different prices over 30 days

Product Specifications
Format
paperback
ASIN
B00E4G466A
Category
Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
24 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States

£495.00 08 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Asia
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Asia

£325.00 12 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in India

£495.00 07 Jan 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan
98% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Japan

£495.00 15 Feb 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China
97% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Greater China

£495.00 12 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe

£325.00 24 Jan 2026
The 2013-2018 Outlook for Pipettes and Pipettors in Europe
95% match

The 2013-2018 Outlook for Pipettes and Pipettors in Europe

£325.00 27 Jan 2026
The 2013-2018 Outlook for Anticoagulants in Europe
95% match

The 2013-2018 Outlook for Anticoagulants in Europe

£325.00 22 Jan 2026
The 2013-2018 Outlook for Drug Discovery Technologies in Africa, Europe & the Middle East
95% match

The 2013-2018 Outlook for Drug Discovery Technologies in Africa, Europe & the Middle East

£325.00 20 Apr 2026
The 2013-2018 Outlook for Clinical Chemistry Analyzers and Reagents in Europe
95% match

The 2013-2018 Outlook for Clinical Chemistry Analyzers and Reagents in Europe

£325.00 08 Jan 2026
The 2013-2018 Outlook for Online Health and Pharmacy-Related Products in Europe
95% match

The 2013-2018 Outlook for Online Health and Pharmacy-Related Products in Europe

£325.00 26 Jan 2026
The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Europe
95% match

The 2013-2018 Outlook for Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Europe

£325.00 13 Jan 2026
The 2013-2018 Outlook for E-Paper Displays in Europe
95% match

The 2013-2018 Outlook for E-Paper Displays in Europe

£325.00 31 Jan 2026
The 2013-2018 Outlook for Medical Devices and Diagnostics in Europe
95% match

The 2013-2018 Outlook for Medical Devices and Diagnostics in Europe

£325.00 12 Jan 2026
The 2013 Report on Dipeptidyl Peptidase IV (DPP-IV) Inhibitors: World Market Segmentation by City
95% match

The 2013 Report on Dipeptidyl Peptidase IV (DPP-IV) Inhibitors: World Market Segmentation by City

£795.00 12 Feb 2026
The 2013-2018 Outlook for Blood Pressure Transducers in Europe
95% match

The 2013-2018 Outlook for Blood Pressure Transducers in Europe

£325.00 13 Jan 2026
The 2013-2018 Outlook for Fermentation Chemicals in Europe
95% match

The 2013-2018 Outlook for Fermentation Chemicals in Europe

£325.00 27 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
95% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 31 Mar 2026
The 2013-2018 Outlook for Herbal Supplements and Remedies in Europe
94% match

The 2013-2018 Outlook for Herbal Supplements and Remedies in Europe

£325.00 26 Jan 2026
The 2013-2018 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Europe
94% match

The 2013-2018 Outlook for Human Immunodeficiency Virus (HIV) Treatments in Europe

£325.00 23 Jan 2026
The 2013-2018 Outlook for Spectrometers, Spectrophotometers, and Spectrofluorometers in Europe
94% match

The 2013-2018 Outlook for Spectrometers, Spectrophotometers, and Spectrofluorometers in Europe

£325.00 31 Jan 2026
The 2013-2018 Outlook for Personal Therapy Products in Europe
94% match

The 2013-2018 Outlook for Personal Therapy Products in Europe

£325.00 24 Jan 2026
The 2013-2018 Outlook for Emulsifiers in Europe
94% match

The 2013-2018 Outlook for Emulsifiers in Europe

£325.00 25 Jan 2026
The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in Europe
94% match

The 2013-2018 Outlook for Hormone Replacement Therapy (HRT) in Europe

£325.00 12 Jan 2026